Results 241 to 250 of about 183,589 (343)

Corporate Management of Environmental, Social, and Governance Ratings and Rating Divergence

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT As environmental, social, and governance (ESG) ratings increasingly influence investment and corporate decision‐making, companies face growing pressure to manage their ESG performance strategically. This study examines how firms navigate the fragmented ESG rating landscape marked by significant agency divergence. Based on a multiple‐case study
Selina Hauch
wiley   +1 more source

Enhancing Parenting Using AI: Exploratory Hackathon. [PDF]

open access: yesJMIR Form Res
Woods P   +6 more
europepmc   +1 more source

Artificial Intelligence and Environmental, Social, and Governance: A Hybrid Bibliometric Approach

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This study provides a comprehensive overview of research on artificial intelligence (AI) and Environmental, Social, and Governance (ESG) by creating a knowledge map of the field. Using a systematic–bibliometric approach, we quantitatively analyzed a total of 129 documents, which collectively were cited 4276 times (2017–2024).
Qiang (John) Wu   +3 more
wiley   +1 more source

A multimodal experimental dataset on agile software development team interactions. [PDF]

open access: yesData Brief
Miranda D   +7 more
europepmc   +1 more source

The Twin Transition in Practice. Digital Technologies, Sustainability, and the Role of Family Ownership in Europe

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This paper examines whether and to what extent digital technologies (DTs) foster the adoption of environmental sustainability (ES), and how this relationship is moderated by family ownership. Using data from approximately 14,000 European firms surveyed in the Flash Eurobarometer 486, we estimate a recursive simultaneous equation model via a ...
Francesco Aiello   +2 more
wiley   +1 more source

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML. [PDF]

open access: yesBlood Adv
Montesinos P   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy